KDM1A and neoplasm: Hence, the potential utility of LSD1 inhibitors has come to the fore, as they hold promise in rendering tumor cells more readily discernible to the immune system, consequently augmenting the efficacy of immunotherapeutic agents such as immune checkpoint inhibitors.